• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酸氟替卡松在碱性溶液中的降解速率及产物

Degradation rates and products of fluticasone propionate in alkaline solutions.

作者信息

Tokumura Tadakazu, Yoshida Naoko, Mori-Yasumoto Kanami, Shirota Osamu, Kurita Takuro

机构信息

Laboratory of Pharmaceutics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Shido 1314-1, Sanuki, Kagawa 769-2193, Japan.

Department of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare, 2600-1 Kitakanemaru, Ohtawara, Tochigi 324-8501, Japan.

出版信息

J Pharm Anal. 2017 Oct;7(5):297-302. doi: 10.1016/j.jpha.2017.03.010. Epub 2017 Apr 27.

DOI:10.1016/j.jpha.2017.03.010
PMID:29404052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5790711/
Abstract

The apparent degradation rate constant of fluticasone propionate (FLT) in 0.1 M NaOH:methanol=1:1 at 37 °C was previously reported to be 0.169±0.003 h, and four degradation products (products 1-4) were observed in the solution. The aims of the present study were to assess the degradation rates of FLT in other alkaline solutions and clarify the chemical structures of the four degradation products in order to obtain basic data for designing an enema for inflammatory bowel disease. The apparent degradation rate constants in 0.05 M NaOH and 0.1 M NaOH:CHCN=1:1 were 0.472±0.013 h and 0.154±0.000 h (=3), respectively. The chemical structures of products 1-4 in 0.1 M NaOH:methanol=1:1 were revealed by nuclear magnetic resonance (NMR) and mass spectrometry data. The chemical structure of products 2 was that the 17-position of the thioester moiety of FLT was substituted by a carboxylic acid. The degradation product in 0.1 M NaOH:CHCN=1:1 was found to be product 2 based on H NMR data. The degradation product in 0.05 M NaOH was considered to be product 2 based on the retention time of HPLC. These results are useful for detecting the degradation products of FLT by enzymes of the intestinal bacterial flora in the large intestine after dosing FLT as an enema.

摘要

先前报道,丙酸氟替卡松(FLT)在37℃的0.1M氢氧化钠:甲醇=1:1溶液中的表观降解速率常数为0.169±0.003 h,且在该溶液中观察到四种降解产物(产物1 - 4)。本研究的目的是评估FLT在其他碱性溶液中的降解速率,并阐明这四种降解产物的化学结构,以便获得设计用于治疗炎症性肠病的灌肠剂的基础数据。在0.05M氢氧化钠和0.1M氢氧化钠:乙腈=1:1中的表观降解速率常数分别为0.472±0.013 h和0.154±0.000 h(=3)。通过核磁共振(NMR)和质谱数据揭示了在0.1M氢氧化钠:甲醇=1:1中产物1 - 4的化学结构。产物2的化学结构是FLT硫酯部分的17位被羧酸取代。基于氢核磁共振数据,发现在0.1M氢氧化钠:乙腈=1:1中的降解产物为产物2。基于高效液相色谱的保留时间,认为在0.05M氢氧化钠中的降解产物为产物2。这些结果对于在将FLT作为灌肠剂给药后,检测大肠中肠道菌群的酶对FLT的降解产物很有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/0a6058550252/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/f01853bb686a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/af2c2752137a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/7fa029199aa0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/2ada213cca55/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/40d99191141a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/0a6058550252/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/f01853bb686a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/af2c2752137a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/7fa029199aa0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/2ada213cca55/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/40d99191141a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b58/5790711/0a6058550252/gr6.jpg

相似文献

1
Degradation rates and products of fluticasone propionate in alkaline solutions.丙酸氟替卡松在碱性溶液中的降解速率及产物
J Pharm Anal. 2017 Oct;7(5):297-302. doi: 10.1016/j.jpha.2017.03.010. Epub 2017 Apr 27.
2
Simultaneous analysis of glucocorticosteroid fluticasone propionate and its metabolite fluticasone propionate 17β-carboxylic acid in human plasma by UPLC-MS/MS at sub pg/mL level.采用超高效液相色谱-串联质谱法在亚皮克/毫升水平同时分析人血浆中糖皮质激素丙酸氟替卡松及其代谢产物17β-羧酸丙酸氟替卡松。
J Pharm Biomed Anal. 2017 Feb 20;135:1-7. doi: 10.1016/j.jpba.2016.12.008. Epub 2016 Dec 8.
3
Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo.布地奈德和氟替卡松在人体鼻腔中的潴留:体内气道黏膜布地奈德酯的形成。
Br J Clin Pharmacol. 2001 Feb;51(2):159-63. doi: 10.1111/j.1365-2125.2001.01303.x.
4
Thermal and alkaline stability of meropenem: degradation products and cytotoxicity.美罗培南的热稳定性和碱稳定性:降解产物与细胞毒性
Int J Pharm. 2008 Feb 28;350(1-2):95-102. doi: 10.1016/j.ijpharm.2007.08.023. Epub 2007 Aug 24.
5
Assessment of lisdexamfetamine dimesylate stability and identification of its degradation product by NMR spectroscopy.通过核磁共振波谱法评估赖氨酸右旋苯丙胺二甲硫酸盐的稳定性并鉴定其降解产物。
Drug Dev Ind Pharm. 2019 Jan;45(1):139-146. doi: 10.1080/03639045.2018.1526185. Epub 2018 Nov 1.
6
Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.采用超高效液相色谱、超高效液相色谱-四极杆飞行时间串联质谱和核磁共振对尼达尼布的应激降解产物进行表征:一种具有致突变性结构警示的降解产物的证据。
J Pharm Biomed Anal. 2021 May 30;199:114037. doi: 10.1016/j.jpba.2021.114037. Epub 2021 Mar 24.
7
The physico-chemical properties of salmeterol and fluticasone propionate in different solvent environments.
Int J Pharm. 2000 May 10;200(2):279-88. doi: 10.1016/s0378-5173(00)00397-5.
8
Identification of chemicals leaching from dental resin-based materials after in vitro chemical and salivary degradation.体外化学和唾液降解后牙科树脂基材料中浸出化学物质的鉴定
Dent Mater. 2022 Jan;38(1):19-32. doi: 10.1016/j.dental.2021.10.006. Epub 2021 Nov 10.
9
Identification, characterization and in silico ADMET prediction of Roflumilast degradation products.罗氟司特降解产物的鉴定、表征及计算机辅助ADMET预测
J Pharm Biomed Anal. 2017 May 10;138:126-133. doi: 10.1016/j.jpba.2017.02.012. Epub 2017 Feb 6.
10
Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects.舒利迭干粉吸入剂(沙美特罗替卡松)在健康受试者中的药代动力学。
J Aerosol Med Pulm Drug Deliv. 2018 Oct;31(5):290-297. doi: 10.1089/jamp.2017.1437. Epub 2018 Mar 1.

本文引用的文献

1
A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation Approach.使用基于模型的模拟方法对血浆药代动力学检测丙酸氟替卡松吸入产品肺部性能差异的敏感性进行系统分析。
AAPS J. 2015 Jul;17(4):999-1010. doi: 10.1208/s12248-015-9768-y. Epub 2015 May 2.
2
Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.糖皮质激素治疗炎症性肠病及减少全身作用的方法。
Therap Adv Gastroenterol. 2013 Mar;6(2):137-56. doi: 10.1177/1756283X12473675.
3
New steroids for inflammatory bowel disease.
新型甾体类药物治疗炎症性肠病。
Inflamm Bowel Dis. 1995 Summer;1(2):135-41.
4
[The 39th scientific meeting: perspectives of internal medicine: the cutting edge of treatment of medical disorders encountered in clinical practice; 8. Recent advances in the treatment of inflammatory bowel diseases].
Nihon Naika Gakkai Zasshi. 2012 Mar 10;101(3):643-6. doi: 10.2169/naika.101.643.
5
[Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].[从沙美特罗与丙酸氟替卡松单剂吸入装置转换为联合吸入装置对哮喘患者的影响]
Arerugi. 2008 Nov;57(11):1134-44.
6
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.炎症性肠病:流行病学、发病机制及治疗机遇
Inflamm Bowel Dis. 2006 Jan;12 Suppl 1:S3-9. doi: 10.1097/01.mib.0000195385.19268.68.
7
Role of cytokines in the pathogenesis of inflammatory bowel disease.细胞因子在炎症性肠病发病机制中的作用。
Annu Rev Med. 2000;51:289-98. doi: 10.1146/annurev.med.51.1.289.
8
Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.吸入丙酸氟替卡松全身吸收的颊部成分评估。
Thorax. 1999 Jul;54(7):614-7. doi: 10.1136/thx.54.7.614.
9
Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the Brit. Assoc. of Accident and Emergency Medicine, and the Brit. Paediatric Respiratory Group.哮喘管理指南。由英国胸科学会、英国儿科学会、伦敦皇家内科医师学院研究部、国王基金中心、全国哮喘运动组织、皇家全科医师学院、哮喘全科医师小组、英国急诊医学协会以及英国儿科呼吸小组发布的声明。
Thorax. 1993 Mar;48(2 Suppl):S1-24. doi: 10.1136/thx.48.2_suppl.s1.
10
Pharmacology of fluticasone propionate.
Respir Med. 1994 Aug;88 Suppl A:5-8. doi: 10.1016/s0954-6111(05)80034-4.